{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:22:10Z","timestamp":1762161730982,"version":"build-2065373602"},"reference-count":5,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Malignant lymphoproliferative disorders in the spleen may be primary (usually designated as splenic lymphoma) or secondary (due to progression of nodal or extra nodal lymphoid neoplasms) and represent an underestimated cause of splenomegaly, partially due to the decreasing frequency of splenectomy in our era of personalized molecular medicine [...]<\/jats:p>","DOI":"10.3390\/curroncol29010011","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T01:18:15Z","timestamp":1640654295000},"page":"130-131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Introduction to a Special Issue on Low-Grade B Cell Lymphoma in the Spleen"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-9665","authenticated-orcid":false,"given":"Victor E.","family":"Nava","sequence":"first","affiliation":[{"name":"Department of Pathology, The George Washington University, Washington, DC 20037, USA"},{"name":"Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.3390\/curroncol28050297","article-title":"New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas","volume":"28","author":"Donzel","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.3390\/curroncol28060390","article-title":"How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen","volume":"28","author":"Nava","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3390\/curroncol28060407","article-title":"Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma\/Follicular Lymphoma","volume":"28","author":"Abdulbaki","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.3390\/curroncol28060430","article-title":"CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen","volume":"28","author":"Schmieg","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.3390\/curroncol28060431","article-title":"A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma","volume":"28","author":"Yilmaz","year":"2021","journal-title":"Curr. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:54:30Z","timestamp":1760169270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["curroncol29010011"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29010011","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}